Who is sponsoring NCT02781103?

NCT02781103 is sponsored by Kenneth M Peters, MD.

What drugs are being tested in NCT02781103?

Interventions in NCT02781103: Guided imagery plus active tDCS, Guided imagery plus Sham tDCS.

What condition does NCT02781103 study?

NCT02781103 studies Cystitis, Interstitial, Pelvic Pain.

Is NCT02781103 still recruiting?

NCT02781103 is currently terminated. Last updated 2 October 2019.

Last reviewed 2019-10-02 · How we verify

NCT02781103

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain

Terminated NA Last updated 2 October 2019

What this trial tests

NA trial testing Guided imagery plus active tDCS in Cystitis, Interstitial in 1 participant. Terminated before completion.

Timeline

20 January 2017

Primary endpoint
13 February 2017

26 September 2019

Quick facts

Lead sponsor	Kenneth M Peters, MD
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	1
Start date	20 January 2017
Primary completion	13 February 2017
Estimated completion	26 September 2019
Sites	1 location across United States

Drugs / interventions tested

Guided imagery plus active tDCS
Guided imagery plus Sham tDCS

Conditions studied

Cystitis, Interstitial — all drugs for Cystitis, Interstitial →
Pelvic Pain — all drugs for Pelvic Pain →

Sponsor

Kenneth M Peters, MD

Who can join

Adults 18 to 64, female only, with Cystitis, Interstitial or Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single blind, randomized controlled pilot trial of transcranial direct stimulation (tDCS) intervention or tDCS sham administered with a standardized guided imagery intervention. Up to 25 adult women with chronic pelvic pain will be enrolled and randomized (like a flip of the coin) to achieve a total sample size of 20 women. 10 women in one arm of the study will receive guided imagery with tDCS stimulation. 10 women in the other arm of the study will receive guided imagery with sham tDCS. Subjects will remain blinded until the end of the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cystitis, Interstitial

Currently open trials in the same condition.

NCT06299683 — Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02781103 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kenneth M Peters, MD
Last refreshed: 2 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02781103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing